NCT06162949View on ClinicalTrials.gov

Vonoprazan for Helicobacter Pylori Eradication in Adolescents

PHASE3CompletedINTERVENTIONAL
Enrollment

242

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

August 1, 2024

Study Completion Date

August 1, 2024

Conditions
Treatment Effectiveness
Interventions
DRUG

Vonoprazan

an acid suppressor therapy that inhibits the H+, K+-ATPase enzyme system in a potassium-competitive manner.

DRUG

Amoxicillin

An antibiotic of penicillins antibiotic group

DRUG

Clarithromycin

An antibiotic of macrolide group

DRUG

Esomeprazole

An acid suppressor therapy that blocks the proton pump.

Trial Locations (1)

21521

Faculty of Medicine, Alexandria

All Listed Sponsors
lead

Alexandria University

OTHER

NCT06162949 - Vonoprazan for Helicobacter Pylori Eradication in Adolescents | Biotech Hunter | Biotech Hunter